| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 6.78e-11 | 15 | 11 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 3.00e-07 | 112 | 11 | 4 | GO:0090079 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 1.09e-05 | 276 | 11 | 4 | GO:0003730 | |
| GeneOntologyMolecularFunction | translation regulator activity | 6.97e-05 | 443 | 11 | 4 | GO:0045182 | |
| GeneOntologyMolecularFunction | mRNA binding | 3.93e-04 | 694 | 11 | 4 | GO:0003729 | |
| GeneOntologyBiologicalProcess | female meiosis II | 6.56e-13 | 6 | 11 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 6.56e-13 | 6 | 11 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 6.56e-13 | 6 | 11 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 6.50e-10 | 26 | 11 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.03e-09 | 29 | 11 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 1.37e-09 | 31 | 11 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 2.87e-09 | 37 | 11 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 6.45e-09 | 45 | 11 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 7.72e-09 | 47 | 11 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 1.17e-08 | 52 | 11 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 5.22e-08 | 75 | 11 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 5.81e-08 | 77 | 11 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 7.50e-08 | 82 | 11 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 9.53e-08 | 87 | 11 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 9.98e-08 | 88 | 11 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 1.14e-07 | 91 | 11 | 4 | GO:0006446 | |
| GeneOntologyBiologicalProcess | cell maturation | 1.52e-07 | 267 | 11 | 5 | GO:0048469 | |
| GeneOntologyBiologicalProcess | oocyte development | 1.61e-07 | 99 | 11 | 4 | GO:0048599 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 1.74e-07 | 101 | 11 | 4 | GO:1902369 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 1.88e-07 | 103 | 11 | 4 | GO:0009994 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 2.94e-07 | 115 | 11 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 3.26e-07 | 118 | 11 | 4 | GO:2000243 | |
| GeneOntologyBiologicalProcess | translational initiation | 5.11e-07 | 132 | 11 | 4 | GO:0006413 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 6.14e-07 | 354 | 11 | 5 | GO:0071695 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 8.75e-07 | 151 | 11 | 4 | GO:0045727 | |
| GeneOntologyBiologicalProcess | oogenesis | 9.97e-07 | 156 | 11 | 4 | GO:0048477 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 1.47e-06 | 172 | 11 | 4 | GO:0051783 | |
| GeneOntologyBiologicalProcess | developmental maturation | 1.77e-06 | 439 | 11 | 5 | GO:0021700 | |
| GeneOntologyBiologicalProcess | female gamete generation | 4.14e-06 | 223 | 11 | 4 | GO:0007292 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 5.53e-06 | 240 | 11 | 4 | GO:0140013 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 6.61e-06 | 251 | 11 | 4 | GO:2000241 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 8.56e-06 | 268 | 11 | 4 | GO:1903046 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 1.20e-05 | 292 | 11 | 4 | GO:0043488 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 1.46e-05 | 307 | 11 | 4 | GO:0090068 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 1.48e-05 | 308 | 11 | 4 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 1.50e-05 | 309 | 11 | 4 | GO:0061013 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 2.45e-05 | 350 | 11 | 4 | GO:0051321 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 3.14e-05 | 373 | 11 | 4 | GO:0006402 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 4.42e-05 | 407 | 11 | 4 | GO:0045787 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 4.90e-05 | 418 | 11 | 4 | GO:0009895 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 5.57e-05 | 432 | 11 | 4 | GO:0006401 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 6.15e-05 | 443 | 11 | 4 | GO:1903311 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 7.36e-05 | 464 | 11 | 4 | GO:0141188 | |
| GeneOntologyBiologicalProcess | germ cell development | 8.53e-05 | 482 | 11 | 4 | GO:0007281 | |
| GeneOntologyBiologicalProcess | regulation of translation | 9.38e-05 | 494 | 11 | 4 | GO:0006417 | |
| GeneOntologyBiologicalProcess | nuclear division | 1.08e-04 | 512 | 11 | 4 | GO:0000280 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | 1.21e-04 | 527 | 11 | 4 | GO:0022412 | |
| GeneOntologyBiologicalProcess | organelle fission | 1.64e-04 | 571 | 11 | 4 | GO:0048285 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | 1.68e-04 | 574 | 11 | 4 | GO:0010638 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | 2.60e-04 | 1235 | 11 | 5 | GO:0003006 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 3.51e-04 | 696 | 11 | 4 | GO:0034655 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | 3.84e-04 | 1342 | 11 | 5 | GO:0033043 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | 4.17e-04 | 1366 | 11 | 5 | GO:0051130 | |
| GeneOntologyBiologicalProcess | spermatogenesis | 4.52e-04 | 744 | 11 | 4 | GO:0007283 | |
| GeneOntologyBiologicalProcess | male gamete generation | 4.95e-04 | 762 | 11 | 4 | GO:0048232 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | 5.43e-04 | 1446 | 11 | 5 | GO:0010628 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | 5.64e-04 | 1458 | 11 | 5 | GO:0051247 | |
| GeneOntologyBiologicalProcess | translation | 6.66e-04 | 824 | 11 | 4 | GO:0006412 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 7.33e-04 | 845 | 11 | 4 | GO:0010564 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 9.97e-04 | 917 | 11 | 4 | GO:0016071 | |
| GeneOntologyBiologicalProcess | gamete generation | 1.29e-03 | 982 | 11 | 4 | GO:0007276 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 2.33e-03 | 1153 | 11 | 4 | GO:0010608 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | 2.65e-03 | 1194 | 11 | 4 | GO:0048609 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | 3.16e-03 | 1252 | 11 | 4 | GO:0009894 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | 3.20e-03 | 1256 | 11 | 4 | GO:0051726 | |
| GeneOntologyBiologicalProcess | sexual reproduction | 3.75e-03 | 1312 | 11 | 4 | GO:0019953 | |
| GeneOntologyBiologicalProcess | biomineral tissue development | 5.00e-03 | 203 | 11 | 2 | GO:0031214 | |
| GeneOntologyBiologicalProcess | cell cycle process | 5.26e-03 | 1441 | 11 | 4 | GO:0022402 | |
| GeneOntologyCellularComponent | ribosome | 8.00e-06 | 267 | 11 | 4 | GO:0005840 | |
| HumanPheno | Oligozoospermia | 1.96e-06 | 59 | 9 | 4 | HP:0000798 | |
| HumanPheno | Y-linked inheritance | 3.07e-06 | 18 | 9 | 3 | HP:0001450 | |
| HumanPheno | Decreased testicular size | 2.49e-04 | 200 | 9 | 4 | HP:0008734 | |
| HumanPheno | Male infertility | 2.95e-04 | 209 | 9 | 4 | HP:0003251 | |
| HumanPheno | Aplasia/Hypoplasia of the testes | 3.66e-04 | 221 | 9 | 4 | HP:0010468 | |
| HumanPheno | Decreased fertility in males | 4.71e-04 | 236 | 9 | 4 | HP:0012041 | |
| HumanPheno | Abnormality of the testis size | 4.86e-04 | 238 | 9 | 4 | HP:0045058 | |
| MousePheno | absent ovarian follicles | 1.95e-08 | 51 | 9 | 4 | MP:0002777 | |
| MousePheno | small ovary | 3.05e-06 | 178 | 9 | 4 | MP:0001127 | |
| MousePheno | abnormal ovarian follicle number | 5.14e-06 | 203 | 9 | 4 | MP:0008871 | |
| MousePheno | abnormal ovary size | 8.15e-06 | 228 | 9 | 4 | MP:0004853 | |
| MousePheno | arrest of spermatogenesis | 9.82e-06 | 239 | 9 | 4 | MP:0001155 | |
| MousePheno | abnormal ovarian follicle morphology | 1.08e-05 | 245 | 9 | 4 | MP:0001131 | |
| MousePheno | abnormal seminiferous tubule morphology | 5.89e-05 | 377 | 9 | 4 | MP:0002216 | |
| MousePheno | oligozoospermia | 6.33e-05 | 384 | 9 | 4 | MP:0002687 | |
| MousePheno | female infertility | 8.17e-05 | 410 | 9 | 4 | MP:0001926 | |
| MousePheno | abnormal ovary morphology | 1.18e-04 | 451 | 9 | 4 | MP:0001126 | |
| MousePheno | abnormal female reproductive gland morphology | 1.45e-04 | 475 | 9 | 4 | MP:0013324 | |
| MousePheno | abnormal sperm number | 4.14e-04 | 624 | 9 | 4 | MP:0002673 | |
| MousePheno | decreased male germ cell number | 4.56e-04 | 640 | 9 | 4 | MP:0004901 | |
| MousePheno | decreased germ cell number | 5.98e-04 | 687 | 9 | 4 | MP:0002209 | |
| MousePheno | abnormal internal female genitalia morphology | 8.64e-04 | 757 | 9 | 4 | MP:0009209 | |
| MousePheno | abnormal female genitalia morphology | 8.90e-04 | 763 | 9 | 4 | MP:0009208 | |
| MousePheno | abnormal female reproductive system morphology | 9.03e-04 | 766 | 9 | 4 | MP:0001119 | |
| MousePheno | abnormal gametes | 9.91e-04 | 785 | 9 | 4 | MP:0001124 | |
| MousePheno | small testis | 1.18e-03 | 823 | 9 | 4 | MP:0001147 | |
| MousePheno | abnormal male germ cell morphology | 1.39e-03 | 859 | 9 | 4 | MP:0006362 | |
| MousePheno | abnormal female reproductive system physiology | 1.50e-03 | 876 | 9 | 4 | MP:0003699 | |
| MousePheno | small gonad | 1.55e-03 | 885 | 9 | 4 | MP:0001116 | |
| MousePheno | abnormal primary sex determination | 1.66e-03 | 901 | 9 | 4 | MP:0002211 | |
| MousePheno | abnormal spermatogenesis | 1.73e-03 | 910 | 9 | 4 | MP:0001156 | |
| MousePheno | abnormal testis size | 1.76e-03 | 915 | 9 | 4 | MP:0004849 | |
| MousePheno | male infertility | 1.98e-03 | 944 | 9 | 4 | MP:0001925 | |
| MousePheno | abnormal sex determination | 1.99e-03 | 945 | 9 | 4 | MP:0002210 | |
| MousePheno | abnormal germ cell morphology | 1.99e-03 | 946 | 9 | 4 | MP:0002208 | |
| MousePheno | abnormal foam cell morphology | 2.06e-03 | 954 | 9 | 4 | MP:0009840 | |
| MousePheno | abnormal gametogenesis | 3.15e-03 | 1070 | 9 | 4 | MP:0001929 | |
| MousePheno | abnormal testis morphology | 3.27e-03 | 1081 | 9 | 4 | MP:0001146 | |
| MousePheno | infertility | 4.62e-03 | 1188 | 9 | 4 | MP:0001924 | |
| MousePheno | abnormal male reproductive gland morphology | 6.22e-03 | 1290 | 9 | 4 | MP:0013325 | |
| MousePheno | abnormal male reproductive system physiology | 6.93e-03 | 1329 | 9 | 4 | MP:0003698 | |
| MousePheno | abnormal internal male genitalia morphology | 8.18e-03 | 1392 | 9 | 4 | MP:0009205 | |
| MousePheno | abnormal male reproductive system morphology | 8.68e-03 | 1415 | 9 | 4 | MP:0001145 | |
| MousePheno | abnormal male genitalia morphology | 8.68e-03 | 1415 | 9 | 4 | MP:0009198 | |
| Domain | RRM_1 | 4.64e-06 | 208 | 11 | 4 | PF00076 | |
| Domain | RRM | 5.49e-06 | 217 | 11 | 4 | SM00360 | |
| Domain | RRM_dom | 6.56e-06 | 227 | 11 | 4 | IPR000504 | |
| Domain | RRM | 6.91e-06 | 230 | 11 | 4 | PS50102 | |
| Domain | - | 8.73e-06 | 244 | 11 | 4 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.09e-05 | 258 | 11 | 4 | IPR012677 | |
| Pathway | WP_OVARIAN_INFERTILITY | 6.61e-09 | 35 | 10 | 4 | MM15948 | |
| Pathway | WP_MALE_INFERTILITY | 2.15e-06 | 145 | 10 | 4 | M39856 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 3.87e-05 | 301 | 10 | 4 | MM15983 | |
| Pathway | WP_MRNA_PROCESSING | 1.86e-04 | 451 | 10 | 4 | MM15946 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 5.41e-15 | 4 | 11 | 4 | 15066457 | |
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 5.41e-15 | 4 | 11 | 4 | 26232607 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 5.41e-15 | 4 | 11 | 4 | 11095434 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 5.41e-15 | 4 | 11 | 4 | 11688365 | |
| Pubmed | 5.41e-15 | 4 | 11 | 4 | 11694340 | ||
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 5.41e-15 | 4 | 11 | 4 | 10936047 | |
| Pubmed | 5.41e-15 | 4 | 11 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 5.41e-15 | 4 | 11 | 4 | 11883873 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 5.41e-15 | 4 | 11 | 4 | 16963411 | |
| Pubmed | 5.41e-15 | 4 | 11 | 4 | 9321470 | ||
| Pubmed | 5.41e-15 | 4 | 11 | 4 | 7670487 | ||
| Pubmed | 5.41e-15 | 4 | 11 | 4 | 19223287 | ||
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 5.41e-15 | 4 | 11 | 4 | 12801575 | |
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 23456578 | ||
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 17761180 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 2.71e-14 | 5 | 11 | 4 | 8679003 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 2.71e-14 | 5 | 11 | 4 | 10903443 | |
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 2.71e-14 | 5 | 11 | 4 | 10393944 | |
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 23298641 | ||
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 23579190 | ||
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 2.71e-14 | 5 | 11 | 4 | 8968756 | |
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 2.71e-14 | 5 | 11 | 4 | 30380414 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 2.71e-14 | 5 | 11 | 4 | 23223451 | |
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 34985827 | ||
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 11804965 | ||
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 19468308 | ||
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 9143498 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 2.71e-14 | 5 | 11 | 4 | 14648873 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 2.71e-14 | 5 | 11 | 4 | 26411291 | |
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 2.71e-14 | 5 | 11 | 4 | 22223682 | |
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 2.71e-14 | 5 | 11 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 2.71e-14 | 5 | 11 | 4 | 8845845 | |
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 8896558 | ||
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 9700189 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 2.71e-14 | 5 | 11 | 4 | 12200456 | |
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 11058556 | ||
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 2.71e-14 | 5 | 11 | 4 | 17416365 | |
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 2.71e-14 | 5 | 11 | 4 | 19783541 | |
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 2.71e-14 | 5 | 11 | 4 | 22021443 | |
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 11514340 | ||
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 22293198 | ||
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 21270429 | ||
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 11089564 | ||
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 8661148 | ||
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 2.71e-14 | 5 | 11 | 4 | 9288969 | |
| Pubmed | 2.71e-14 | 5 | 11 | 4 | 20008336 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 8.12e-14 | 6 | 11 | 4 | 18452650 | |
| Pubmed | 8.12e-14 | 6 | 11 | 4 | 32170089 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 8.12e-14 | 6 | 11 | 4 | 15066460 | |
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 8.12e-14 | 6 | 11 | 4 | 14611632 | |
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 8.12e-14 | 6 | 11 | 4 | 19247806 | |
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 8.12e-14 | 6 | 11 | 4 | 1869307 | |
| Pubmed | 8.12e-14 | 6 | 11 | 4 | 17219433 | ||
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 8.12e-14 | 6 | 11 | 4 | 31355046 | |
| Pubmed | 8.12e-14 | 6 | 11 | 4 | 11390979 | ||
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 8.12e-14 | 6 | 11 | 4 | 23417416 | |
| Pubmed | 8.12e-14 | 6 | 11 | 4 | 28496037 | ||
| Pubmed | 8.12e-14 | 6 | 11 | 4 | 24086306 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 8.12e-14 | 6 | 11 | 4 | 26077710 | |
| Pubmed | 8.12e-14 | 6 | 11 | 4 | 27632217 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 8.12e-14 | 6 | 11 | 4 | 16001084 | |
| Pubmed | 8.12e-14 | 6 | 11 | 4 | 16278232 | ||
| Pubmed | 8.12e-14 | 6 | 11 | 4 | 32962040 | ||
| Pubmed | 8.12e-14 | 6 | 11 | 4 | 17526644 | ||
| Pubmed | 8.12e-14 | 6 | 11 | 4 | 1638086 | ||
| Pubmed | 8.12e-14 | 6 | 11 | 4 | 20157580 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 1.89e-13 | 7 | 11 | 4 | 16946704 | |
| Pubmed | 1.89e-13 | 7 | 11 | 4 | 10857750 | ||
| Pubmed | 1.89e-13 | 7 | 11 | 4 | 11410654 | ||
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 1.89e-13 | 7 | 11 | 4 | 26826184 | |
| Pubmed | 1.89e-13 | 7 | 11 | 4 | 15081113 | ||
| Pubmed | 1.89e-13 | 7 | 11 | 4 | 22699423 | ||
| Pubmed | 1.89e-13 | 7 | 11 | 4 | 11604102 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 1.89e-13 | 7 | 11 | 4 | 9588208 | |
| Pubmed | 3.79e-13 | 8 | 11 | 4 | 10951504 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 3.79e-13 | 8 | 11 | 4 | 23204224 | |
| Pubmed | 3.79e-13 | 8 | 11 | 4 | 10823932 | ||
| Pubmed | 3.79e-13 | 8 | 11 | 4 | 29883445 | ||
| Pubmed | 3.79e-13 | 8 | 11 | 4 | 22621333 | ||
| Pubmed | 3.79e-13 | 8 | 11 | 4 | 33749946 | ||
| Pubmed | 3.79e-13 | 8 | 11 | 4 | 32686646 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 3.79e-13 | 8 | 11 | 4 | 32339196 | |
| Pubmed | 3.79e-13 | 8 | 11 | 4 | 11869379 | ||
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 6.82e-13 | 9 | 11 | 4 | 26378784 | |
| Pubmed | 6.82e-13 | 9 | 11 | 4 | 20159962 | ||
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 6.82e-13 | 9 | 11 | 4 | 19695304 | |
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 6.82e-13 | 9 | 11 | 4 | 16310179 | |
| Pubmed | 6.82e-13 | 9 | 11 | 4 | 28235998 | ||
| Pubmed | 1.14e-12 | 10 | 11 | 4 | 9922113 | ||
| Pubmed | 1.14e-12 | 10 | 11 | 4 | 31234534 | ||
| Pubmed | 1.14e-12 | 10 | 11 | 4 | 23810942 | ||
| Pubmed | 1.14e-12 | 10 | 11 | 4 | 12837688 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 1.14e-12 | 10 | 11 | 4 | 14648882 | |
| Pubmed | 1.14e-12 | 10 | 11 | 4 | 10601091 | ||
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 1.14e-12 | 10 | 11 | 4 | 38433229 | |
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 1.78e-12 | 11 | 11 | 4 | 34401671 | |
| Pubmed | Retinoic acid activates two pathways required for meiosis in mice. | 2.68e-12 | 12 | 11 | 4 | 25102060 | |
| Pubmed | Germ cell-intrinsic and -extrinsic factors govern meiotic initiation in mouse embryos. | 2.68e-12 | 12 | 11 | 4 | 19074348 | |
| Pubmed | Licensing of primordial germ cells for gametogenesis depends on genital ridge signaling. | 2.68e-12 | 12 | 11 | 4 | 25739037 | |
| Interaction | PUM2 interactions | 5.65e-05 | 144 | 11 | 3 | int:PUM2 | |
| Cytoband | Yq11.223 | 5.15e-09 | 93 | 11 | 4 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 6.57e-07 | 311 | 11 | 4 | chrYq11 | |
| GeneFamily | RNA binding motif containing | 6.38e-07 | 213 | 7 | 4 | 725 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 8.29e-12 | 12 | 11 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 8.29e-12 | 12 | 11 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 1.48e-10 | 23 | 11 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 5.25e-10 | 31 | 11 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 6.83e-10 | 33 | 11 | 4 | MM701 | |
| Coexpression | MCCABE_BOUND_BY_HOXC6 | 1.23e-08 | 461 | 11 | 6 | M6376 | |
| Coexpression | MADAN_DPPA4_TARGETS | 3.50e-08 | 86 | 11 | 4 | MM1312 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 4.81e-08 | 93 | 11 | 4 | MM1185 | |
| Coexpression | GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP | 3.55e-05 | 160 | 11 | 3 | M7116 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | 6.65e-05 | 574 | 11 | 4 | MM820 | |
| Coexpression | GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 6.80e-05 | 199 | 11 | 3 | M7548 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 3.90e-04 | 909 | 11 | 4 | M41018 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Cyp26b1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.72e-05 | 54 | 11 | 2 | 4daa84df51cc99113a9f8e86b1ae09bd76a9c991 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Cyp26b1_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.72e-05 | 54 | 11 | 2 | 2e177a9fd0f7c033dbcfa8b41b76658d8268644c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT1-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-04 | 112 | 11 | 2 | 456278fb92dd41820fde8cf27c68fec45e15f972 | |
| ToppCell | droplet-Liver-Npc-21m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-04 | 155 | 11 | 2 | d883a3869cf893d62741f26f641ed3923aba03f9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.72e-04 | 171 | 11 | 2 | f047a0cc2ce0a062ec502aa9cb91b1202f437f29 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-04 | 175 | 11 | 2 | 046e841811b22c39f80a9752f3223c1906de6f20 | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.55e-04 | 180 | 11 | 2 | 708a5c89b9337e281fce4f482892a1c1766c7812 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-04 | 183 | 11 | 2 | 28916f0597690ff534578be2cb715b485cb1de1a | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-04 | 183 | 11 | 2 | 99ab7a43527eb226027efbcd8c0b6a8e46fc3c93 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.93e-04 | 184 | 11 | 2 | 89302321b0949d5b57047b75dd16049aac9a2a3f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-04 | 184 | 11 | 2 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-04 | 184 | 11 | 2 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.03e-04 | 185 | 11 | 2 | 2c07991e0907ded67e21ab2e66be21695842ed01 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.03e-04 | 185 | 11 | 2 | 37db8e0b1f59274227f6fc2362167eb44bd080ef | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.03e-04 | 185 | 11 | 2 | 2c1f14f77faeee2acb388d997c5a27a7fef79be1 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.03e-04 | 185 | 11 | 2 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.22e-04 | 187 | 11 | 2 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.22e-04 | 187 | 11 | 2 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.22e-04 | 187 | 11 | 2 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.32e-04 | 188 | 11 | 2 | 1a751452c0f1f34b3c20fad2fb52c378ab2d0207 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 9.32e-04 | 188 | 11 | 2 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-04 | 190 | 11 | 2 | f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-04 | 190 | 11 | 2 | 2abeb013bb83c578e67dcb985ba44ca63134950b | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-04 | 191 | 11 | 2 | d1205aab0937f2becfcd239610e9b78fb8a0c886 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-04 | 192 | 11 | 2 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.72e-04 | 192 | 11 | 2 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.72e-04 | 192 | 11 | 2 | 2dee0402e97e48157e0bc01bcc8034f1645dfb7b | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-04 | 192 | 11 | 2 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 9.72e-04 | 192 | 11 | 2 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | LAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class | 9.82e-04 | 193 | 11 | 2 | 68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.92e-04 | 194 | 11 | 2 | f44394c8a6f86483063f2f5722f003a8a0a70254 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-midbrain/hindbrain_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-03 | 196 | 11 | 2 | 0767581b69bc7e6334d580ca02ed1e831b7b55da | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.01e-03 | 196 | 11 | 2 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-03 | 196 | 11 | 2 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 1.02e-03 | 197 | 11 | 2 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 1.02e-03 | 197 | 11 | 2 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-03 | 197 | 11 | 2 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-03 | 197 | 11 | 2 | 2d92b0483d57541aee382dda80e42cf66e813d6b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-03 | 197 | 11 | 2 | 4961f66606f08e399508fd6cabca588e7ab406a8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-03 | 197 | 11 | 2 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-03 | 197 | 11 | 2 | 86157ba4f9a40a80bab2404684fe5a7b4ee380c5 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.03e-03 | 198 | 11 | 2 | b73b9feb82997b654718aa27f33ca7b454214802 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 1.04e-03 | 199 | 11 | 2 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-03 | 199 | 11 | 2 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-03 | 199 | 11 | 2 | 9838fed26d8572ac29e7b5fd7220180f734d750a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-03 | 199 | 11 | 2 | 0cd3e4e0fba000c996feaf012ff32198e1048c9d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 1.04e-03 | 199 | 11 | 2 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-03 | 199 | 11 | 2 | 6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-03 | 199 | 11 | 2 | e09bd3153dd60d06584707b259c78375b47415c8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-03 | 199 | 11 | 2 | 5de2a32bc2e9c752eb19a013b1807949153728fc | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 1.04e-03 | 199 | 11 | 2 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-03 | 199 | 11 | 2 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 1.04e-03 | 199 | 11 | 2 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-03 | 199 | 11 | 2 | 77b4aa00f14b86ef5db0490be98787e063979541 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Neuronal|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-03 | 199 | 11 | 2 | f94307958cead25d38103fcbb35fa45011de1687 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-03 | 199 | 11 | 2 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-03 | 199 | 11 | 2 | a255484ba77bd2741a541da278efc8cf4abbe570 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-03 | 199 | 11 | 2 | cfe6f881a86607544e1413ef38e4b6797ef1a61c | |
| ToppCell | distal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-03 | 199 | 11 | 2 | 547a7c30abc730af2670aee00c7a6af60426c9ac | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.04e-03 | 199 | 11 | 2 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | 306926cb7a847871641f02e03d52dc56fd55711c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-03 | 200 | 11 | 2 | ac5843142e0f8a5bcd2c3a784ea13b2f955a32fd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.05e-03 | 200 | 11 | 2 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Cortical_neuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | db2dbd31dd02c0d1c1070ed5548ce949227e4775 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Cortical_neuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | 085060d148158f7d9e938b6c4a3700ccbb3bca15 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | 979258173b82f37aeaaedd53b4a527da1dbe1b80 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | c248233b004f8ef0bab3c65ecfe295887966f2ee | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Interneuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | c7e33057466915d4e2b34f2062b22d9cdffa69dc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | 19055194a5e0ea122f1b8fc62df44813f6843c95 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | 60b86c4a4e247b2673d31b085b440a6e574393bb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | af99d90070e2933fd2e9512590c6cf3bd6e15539 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-03 | 200 | 11 | 2 | 5a5d70bfb6d253f272cc1f8516205fcfe8106291 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Interneuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | 08bee924a2654e05df3b39e8a51f93c8b3472175 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-03 | 200 | 11 | 2 | 9b5753726c17dda98d7384a60f26a5eaf4f6c4d6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.05e-03 | 200 | 11 | 2 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| Drug | boron trichloride | 4.42e-13 | 6 | 11 | 4 | CID000025135 | |
| Drug | desmethylazelastine | 5.35e-11 | 16 | 11 | 4 | CID000162558 | |
| Drug | dazmegrel | 1.14e-10 | 19 | 11 | 4 | CID000053555 | |
| Drug | YM 026 | 1.14e-10 | 19 | 11 | 4 | CID000004443 | |
| Drug | dansylaziridine | 2.60e-10 | 23 | 11 | 4 | CID000104008 | |
| Drug | AZFd | 2.60e-10 | 23 | 11 | 4 | CID000196489 | |
| Drug | BW755C | 4.62e-10 | 93 | 11 | 5 | CID000047795 | |
| Drug | d-gluconhydroximo-1,5-lactam | 9.21e-10 | 31 | 11 | 4 | CID000003479 | |
| Drug | Vistar | 1.72e-09 | 36 | 11 | 4 | CID000040896 | |
| Drug | 3-bromo-7-nitroindazole | 1.72e-09 | 36 | 11 | 4 | CID000001649 | |
| Drug | molybdenum disulfide | 3.60e-09 | 43 | 11 | 4 | CID000014823 | |
| Drug | 2-chlorodideoxyadenosine | 3.60e-09 | 43 | 11 | 4 | CID000072194 | |
| Drug | propham | 3.96e-09 | 44 | 11 | 4 | CID000024685 | |
| Drug | ridogrel | 7.89e-09 | 52 | 11 | 4 | CID005362391 | |
| Drug | azafagomine | 1.15e-08 | 57 | 11 | 4 | CID011957435 | |
| Drug | NSC56408 | 1.62e-08 | 62 | 11 | 4 | CID000005604 | |
| Drug | kt S | 2.09e-08 | 66 | 11 | 4 | CID006399216 | |
| Drug | azelastine | 3.33e-08 | 74 | 11 | 4 | CID000002267 | |
| Drug | p11-13 | 3.52e-08 | 75 | 11 | 4 | CID000015759 | |
| Drug | bipy | 9.98e-08 | 97 | 11 | 4 | CID000001474 | |
| Drug | carbonyl sulfide | 2.05e-07 | 116 | 11 | 4 | CID000010039 | |
| Drug | TXB2 (thromboxane B2 | 2.20e-07 | 118 | 11 | 4 | CID000005461 | |
| Drug | thromboxane | 2.80e-06 | 223 | 11 | 4 | CID000114873 | |
| Drug | neocarzinostatin chromophore | 7.72e-06 | 288 | 11 | 4 | CID000447545 | |
| Drug | NSC9700 | 1.18e-04 | 578 | 11 | 4 | CID000005408 | |
| Drug | 5-aza-2'-deoxycytidine | 1.72e-04 | 638 | 11 | 4 | CID000016886 | |
| Drug | (+/-)-Jasmonic Acid | 2.53e-03 | 158 | 11 | 2 | CID000105087 | |
| Disease | Male sterility due to Y-chromosome deletions | 7.31e-13 | 8 | 11 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 7.31e-13 | 8 | 11 | 4 | C1507149 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 2.15e-08 | 16 | 11 | 3 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 2.15e-08 | 16 | 11 | 3 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 2.15e-08 | 16 | 11 | 3 | 415000 | |
| Disease | skin aging measurement | 1.98e-03 | 181 | 11 | 2 | EFO_0008006 | |
| Disease | urate measurement, bone density | 2.13e-02 | 619 | 11 | 2 | EFO_0003923, EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YQLPVYNYQPFPAYP | 206 | Q13117 | |
| YQLPVYNYQPFPAYP | 206 | Q9NR90 | |
| PLYYTAPFYPGYTNY | 401 | P78411 | |
| YNRPFFAPYLYTPRY | 1136 | Q9ULH0 | |
| YLFSRYVPTPFVPYA | 146 | Q6PCE3 | |
| YRISYDPARYPRYLP | 96 | Q8TAD2 | |
| FQPFYWPHRYLTYRY | 101 | Q17RF5 | |
| YQLPVYNYQPFPAYP | 536 | Q9NQZ3 | |
| NPYYNYYDTYERPRP | 181 | P28300 | |
| YQLPVYNYQPFPAYP | 371 | Q86SG3 | |
| YYRPLYDAYQPQYSL | 1161 | O15027 |